U.S. stocks fell as consumer and health-care companies pared their monthly gains and investors prepared for policy decisions from central banks while awaiting a slew of economic data this week.
The Standard & Poor’s 500 Index fell 0.4 percent to 2,082.82 at 12 p.m. in New York, after rising less than 0.05 percent last week. The gauge is on track for a second consecutive monthly advance. The Dow Jones Industrial Average slipped 62.93 points, or 0.4 percent, to 17,735.56, and the Nasdaq Composite Index lost 0.4 percent.
The S&P 500 has rebounded 12 percent from its low in August as concern eased that a Chinese slowdown would spread. Fed policy makers have signaled the economy is strong enough to withstand the first U.S. interest-rate increase since 2006, and traders are pricing in a 76 percent chance that the central bank will act at the conclusion of its two-day meeting on December 16.
The U.S. benchmark stock index closed on Friday within 2 percent of its record reached in May while alternating between between gains and losses over the last nine sessions, the longest such streak since 2013. Meanwhile, the Russell 2000 Index of small-cap shares is in the midst of its longest rally this year and is at a three-month high. The gauge is on pace for a 3.4 percent increase this month after rallying 5.6 percent in October.
The Chicago Board Options Exchange Volatility Index rose 9.3 percent Monday to 16.52. The measure of market turbulence known as the VIX slipped for a second straight week, paring its first monthly gain since August’s record increase.